|1.||Kragballe, K: 9 articles (05/2014 - 08/2002)|
|2.||van de Kerkhof, P C M: 8 articles (06/2015 - 02/2004)|
|3.||Cambazard, F: 6 articles (05/2014 - 01/2002)|
|4.||Ganslandt, Cecilia: 5 articles (01/2015 - 07/2010)|
|5.||Rabasseda, X: 5 articles (09/2007 - 07/2004)|
|6.||Prous, J R: 5 articles (09/2007 - 07/2004)|
|7.||de Jong, E M G J: 4 articles (06/2015 - 02/2004)|
|8.||Reich, K: 4 articles (06/2015 - 01/2009)|
|9.||Feldman, Steven R: 4 articles (12/2014 - 01/2007)|
|10.||Ryttov, Jacob: 4 articles (01/2011 - 01/2011)|
|1.||Psoriasis (Pustulosis Palmaris et Plantaris)
01/01/2003 - "Global improvement and global severity scores at treatment endpoint showed statistically significant differences in favour of betamethasone dipropionate (p<0.05); however, the absolute reduction in mean PASI (psoriasis area and severity index) was comparable between the groups. "
01/01/1991 - "Ninety psoriasis patients, who were either completely cleared of or manifested only a minimal presence of disease signs following 3-4 weeks of twice daily treatment with augmented betamethasone dipropionate (ABD) ointment 0.05%, were enrolled in this multicenter, double-blind, placebo-controlled study. "
01/01/1980 - "Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis."
09/01/1983 - "These results did not differ from those of a study on continuous treatment with betamethasone dipropionate cream in the treatment of psoriasis. "
01/01/2010 - "A two-compound product consisting of Cp and betamethasone dipropionate (BD) has become available for the treatment of psoriasis and is clinically superior to both monotherapies. "
01/01/1989 - "A double-blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses."
01/01/1984 - "Treatment of severe or resistant corticosteroid-responsive dermatoses with Diprolene cream."
01/01/1984 - "Diprolene cream in the treatment of severe or resistant corticosteroid-responsive dermatoses."
04/01/2000 - "Thus from this study, supirocin-B ointment (mupirocin 2% + betamethasone dipropionate 0.05%) seems to be safe and effective in the treatment of infected dermatoses."
04/01/2000 - "The aim of the present post marketing study was to study the safety and efficacy of supirocin-B ointment (mupirocin 2% + betamethasone dipropionate 0.05%) in the treatment of infected dermatoses. "
01/01/1984 - "A double-blind study, carried out at two centres, comparing once and twice a day application of betamethasone-17,21-dipropionate cream 0.05% (Diproderm), has shown that the efficacy in treating eczema is the same after 1 week."
01/01/1989 - "Analysis of the diary card records, however, showed that symptomatic relief occurred more quickly in eczema patients receiving twice daily application of betamethasone dipropionate cream (P = 0.03). "
01/01/1994 - "A liposomal preparation of betamethasone dipropionate seems superior to a conventional commercial preparation in eczema but not in psoriasis vulgaris. "
01/01/1997 - "In a randomized, controlled parallel group study we have shown that cyclosporine at 3 mg/kg/day is as effective as topical betamethasone-17,21-dipropionate in the treatment of chronic hand eczema. "
02/01/1996 - "A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema."
07/01/2006 - "Scores for erythema declined significantly at week 12 in both the PDL and the calcipotriol/betamethasone dipropionate group (P<0.001). "
11/01/1989 - "Results significantly favored betamethasone dipropionate AF over fluocinonide, as indicated by improvements in signs of erythema, induration, and scaling, as well as the physicians' and patients' global evaluations of response after 14 days of treatment. "
01/01/2003 - "Both treatments were efficacious; improvement in psoriasis or clearance of lesions (residual erythema was allowed) was recorded for 79% and 82% of patients receiving calcitriol or betamethasone dipropionate, respectively. "
05/01/2009 - "Topical therapy with combined betamethasone dipropionate and calcipotriol induced a higher decrease in erythema, infiltration and desquamation (P<0.001), and a significant reduction of the mean 'bush' diameter (P<0.001) and capillary number/mm(2) (P<0.05) compared with betamethasone and calcipotriol alone. "
|5.||Atopic Dermatitis (Atopic Eczema)
07/01/1976 - "Betamethasone dipropionate ointment in the treatment of psoriasis and atopic dermatitis: a double-blind study."
01/01/1976 - "Betamethasone dipropionate in psoriasis and atopic dermatitis."
01/01/1984 - "In an open study Diprolene Cream was administered to fifty patients with severe or resistant psoriasis, atopic dermatitis or other corticosteroid-responsive dermatoses. "
01/01/1984 - "In a 2-week open study Diprolene Cream was administered to fifty patients with severe or resistant psoriasis, atopic dermatitis or other corticosteroid-responsive dermatoses. "
01/01/1990 - "Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris."
|2.||calcipotriol drug combination betamethasone dipropionate
|3.||Salicylic Acid (2 Hydroxybenzoic Acid)
|5.||Coal Tar (Estar)
|7.||1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)
|10.||TNFR-Fc fusion protein (etanercept)
|4.||Hydrocolloid Bandages (Duoderm)